All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • EIS-12656Phase 21 trial

    Eisbach Bio GmbH · Advanced Solid Tumor, Homologous Recombination Deficiency, HRR Deficiency

  • enpulimabPhase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Advanced Solid Tumor

  • ENV-501Phase 21 trial

    Hummingbird Bioscience · Melanoma (Skin), Non Small Cell Lung Cancer, Breast Cancer

  • EP0062Phase 21 trial

    Ellipses Pharma · Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer

  • EP0089-101Phase 21 trial

    Ellipses Pharma · Solid Cancers, Solid Tumours

  • epacadostatPhase 21 trial

    Incyte · Endometrial Cancer

  • ERAS-0015Phase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • ERAS-601Phase 21 trial

    Erasca, Inc. · Advanced or Metastatic Solid Tumors

  • ES014Phase 21 trial

    Elpiscience (Suzhou) Biopharma, Ltd. · Desmoid Tumor

  • ES102Phase 21 trial

    Elpiscience (Suzhou) Biopharma, Ltd. · Non-Small Cell Lung Cancer

  • ETX-19477Phase 21 trial

    858 Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer

  • ETX-636Phase 21 trial

    Ensem Therapeutics · Advanced Solid Tumors, Advanced Breast Cancer

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • EvalstotugBA3071Phase 21 trial

    BioAtla, Inc. · Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Recurrent Squamous Cell Carcinoma of the Head and Neck

  • EvexomostatSDX-7320Phase 21 trial

    SynDevRx, Inc. · HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer

  • EVM14Phase 21 trial

    Everest Medicines (Beijing) Co., Ltd. · Selected Types of Solid Tumor

  • EVX-01Phase 21 trial

    Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma

  • FamitinibSHR-1020Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Recurrent or Metastatic Cervical Cancer

  • Farletuzumab ecteribulinMORAb-202Phase 21 trial

    Eisai · Solid Tumor

  • FB-1603Phase 21 trial

    Febico Biomedical Corp. · Hepatocellular Carcinoma

  • FB849dose-escalation FB849, dose-expansion of FB849Phase 21 trial

    1ST Biotherapeutics, Inc. · Advanced Solid Tumor

  • FC084CSAPhase 21 trial

    FindCure Biosciences (ZhongShan) Co., Ltd. · Advanced Malignant Solid Tumors

  • FDC fianlimabPhase 21 trial

    Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)

  • FF-10832Gemcitabine LiposomePhase 21 trial

    Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer

  • FG-3246FOR46Phase 21 trial

    Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer

  • FG001Optical imaging agent FG001, Fluorescent imaging agent FG001Phase 21 trial

    FluoGuide A/S · High-Grade Glioma (WHO III-IV)

  • FID007Paclitaxel in Polyethyloxazoline Polymer, Nanoencapsulated Paclitaxel FID-007Phase 21 trial

    Fulgent Pharma LLC. · Head and Neck Squamous Cell Carcinoma

  • FinotonlimabPhase 21 trial

    Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma

  • Fixed cemiplimabPhase 21 trial

    Regeneron · Melanoma

  • FluvustatPhase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer

  • FluzoparibPhase 21 trial

    Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors

  • FLX475tivumecirnonPhase 21 trial

    RAPT Therapeutics, Inc., a member of the GSK plc group of companies · Advanced Cancer

  • FMC-242Phase 21 trial

    Frontier Medicines Corporation · Locally Advanced Solid Tumor

  • FOG-001Phase 21 trial

    Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor

  • Ga-68-NGULPhase 21 trial

    Cellbion Co., Ltd. · Prostate Cancer, mCRPC

  • GAd-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • GAd20-209-FSPPhase 21 trial

    Nouscom SRL · Solid Tumor, Adult

  • gavo-celPhase 21 trial

    TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura

  • GB268Phase 21 trial

    Eddingpharm (Zhuhai) Co., Ltd. · Breast Cancer (Locally Advanced or Metastatic)

  • GDC-1261Phase 21 trial

    Roche (Genentech) · Advanced Prostate Cancer, Metastatic Prostate Cancer

  • GDC-4198RGT-419B, RO7840734Phase 21 trial

    Roche (Genentech) · Breast Cancer

  • GEN-725Phase 21 trial

    Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • GFH925Phase 21 trial

    Genfleet Therapeutics (Shanghai) Inc. · Advance Non-small Cell Lung Cancer

  • GFS202APhase 21 trial

    Genfleet Therapeutics (Shanghai) Inc. · Pancreatic Cancer

  • GI-101Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-101APhase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer

  • GI-108Phase 21 trial

    GI Innovation, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC)

  • GIM-531Phase 21 trial

    Georgiamune Inc · Melanoma Stage IV, Solid Tumor

  • GLS-012Phase 21 trial

    Guangzhou Gloria Biosciences Co., Ltd. · Solid Tumor

NewerPage 18 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.